Accuracy, User Acceptability, and Safety Evaluation for the FreeStyle Libre Flash Glucose Monitoring System When Used by Pregnant Women with Diabetes
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Accuracy of the FreeStyle Libre™ Flash Glucose Monitoring System has not been evaluated in pregnant women with diabetes. The aim of this study was to determine accuracy (compared to self-monitoring of blood glucose [SMBG]), clinical safety, and acceptability of the FreeStyle Libre System when used at home by this population. MATERIALS AND METHODS: Seventy-four participants, with type 1 (T1D, n = 24), type 2 (T2D, n = 11), or gestational (n = 39) diabetes, were enrolled across 13 sites (9 in United Kingdom, 4 in Austria). Average gestation was 26.6 ± 6.8 weeks (mean ± standard deviation), age was 30.5 ± 5.1 years, diabetes duration was 13.1 ± 7.3 years for T1D and 3.2 ± 2.5 years for T2D, and 49/74 (66.2%) used insulin to manage their diabetes. Sensors were worn for up to 14 days. Sensor glucose values (masked) were compared with capillary SMBG values (made at least 4 times/day). RESULTS: Clinical accuracy of sensor results versus SMBG results was demonstrated, with 88.1% and 99.8% of results within Zone A and Zones A and B of the Consensus Error Grid, respectively. Overall mean absolute relative difference was 11.8%. Sensor accuracy was unaffected by the type of diabetes, the stage of pregnancy, whether insulin was used, age or body mass index. User questionnaires indicated high levels of satisfaction with sensor wear, system use, and comparison to SMBG. There were no unanticipated device-related adverse events. CONCLUSIONS: Good agreement was demonstrated between the FreeStyle Libre System and SMBG. Accuracy of the system was unaffected by patient characteristics, indicating that the system is safe and accurate to use by pregnant women with diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Bolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893
Feig, D. S., Donovan, L. E., Corcoy, R., Murphy, K. E., Amiel, S. A., Hunt, K. F., Asztalos, E., Barrett, J. F. R., Sanchez, J. J., de Leiva, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32400-5 · Cited by 803
Self-citationThe Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System
Bailey, T., Bode, B. W., Christiansen, M. P., Klaff, L. J., & Alva, S. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0378 · Cited by 685 · cited 6×
“The study results demonstrated good agreement between the sensor glucose values and capillary blood glucose values, as illustrated through the different statistical and clinical accuracy measures reported, with comparable accuracy to that reported in the nonpregnant population.(23) In a study of 72 adults with T1D and…”
ResultInfluentialHaak, T., Hanaire, H., Ajjan, R., Hermanns, N., Riveline, J.-P., & Rayman, G. (2017) · Diabetes Therapy · doi:10.1007/s13300-016-0223-6 · Cited by 623 · cited 1×
“Other studies have demonstrated that use of the FreeStyle Libre System can significantly reduce the amount of time spent in hypoglycemia.(13,14) Further studies are needed to confirm whether the same improvement can be achieved with its use during pregnancy.”
BackgroundManaging preexisting diabetes for pregnancy
Kitzmiller, J. L., Block, J. M., Brown, F. M., Catalano, P. M., Conway, D. L., Coustan, D. R., Gunderson, E. P., Herman, W. H., Hoffman, L. D., Inturrisi, M., et al. (2008) · Diabetes Care · doi:10.2337/dc08-9020 · Cited by 476 · cited 1×
“pregnancy(7,8)), with more rapid onset of insulin-induced hypoglycemia.(2,9) The risk of severe hypoglycemia is a major barrier to maintaining strict glycemic control, occurring up to five times more frequently during early pregnancy than in the period before pregnancy in women with type 1 diabetes (T1D).”
BackgroundContinuous glucose monitoring: a review of recent studies demonstrating improved glycemic outcomes
Rodbard, D. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0035 · Cited by 458
Murphy, H. R., Rayman, G., Lewis, K., Kelly, S., Johal, B., Duffield, K., Fowler, D., Campbell, P. J., & Temple, R. C. (2008) · BMJ · doi:10.1136/bmj.a1680 · Cited by 358 · cited 1×
“The high user acceptability demonstrated in this study (and in other studies following extended use of the FreeStyle Libre System(13,14)), together with the simplicity of the system and absence of alarms, may imply higher user compliance when using this system than has been observed in CGM studies in pregnancy.(10,15,…”
ResultEffectiveness of Continuous Glucose Monitoring in a Clinical Care Environment
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2010) · Diabetes Care · doi:10.2337/dc09-1502 · Cited by 313
Jensen, D. M., Korsholm, L., Ovesen, P., Beck-Nielsen, H., Moelsted-Pedersen, L., Westergaard, J. G., Moeller, M., & Damm, P. (2009) · Diabetes Care · doi:10.2337/dc08-2061 · Cited by 227
The Effect of Real-Time Continuous Glucose Monitoring in Pregnant Women With Diabetes
Secher, A. L., Ringholm, L., Andersen, H. U., Damm, P., & Mathiesen, E. R. (2013) · Diabetes Care · doi:10.2337/dc12-2360 · Cited by 214
Mauras, N., Beck, R., Xing, D., Ruedy, K., Buckingham, B., Tansey, M., White, N. H., Weinzimer, S. A., Tamborlane, W., Kollman, C., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1746 · Cited by 204
Hypoglycemia in Pregnant Women With Type 1 Diabetes
Nielsen, L. R., Pedersen-Bjergaard, U., Thorsteinsson, B., Johansen, M., Damm, P., & Mathiesen, E. R. (2008) · Diabetes Care · doi:10.2337/dc07-1066 · Cited by 204
Yu, F., Lv, L., Liang, Z., Wang, Y., Wen, J., Lin, X., Zhou, Y., Mai, C., & Niu, J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4332 · Cited by 162
Hypoglycaemia during pregnancy in women with Type 1 diabetes
Ringholm, L., Pedersen‐Bjergaard, U., Thorsteinsson, B., Damm, P., & Mathiesen, E. R. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03604.x · Cited by 101 · cited 1×
“The risk of severe hypoglycemia is a major barrier to maintaining strict glycemic control, occurring up to five times more frequently during early pregnancy than in the period before pregnancy in women with type 1 diabetes (T1D).(10,11) Women with gestational diabetes mellitus (GDM) have a particular challenge, since…”
BackgroundTranslating HbA1c measurements into estimated average glucose values in pregnant women with diabetes
Law, G. R., Gilthorpe, M. S., Secher, A. L., Temple, R., Bilous, R., Mathiesen, E. R., Murphy, H. R., & Scott, E. M. (2017) · Diabetologia · doi:10.1007/s00125-017-4205-7 · Cited by 77
Self-citation
Cited by
Kristensen, K., Ögge, L. E., Sengpiel, V., Kjölhede, K., Dotevall, A., Elfvin, A., Knop, F. K., Wiberg, N., Katsarou, A., Shaat, N., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4850-0 · Cited by 210
7. Diabetes Technology: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s007 · Cited by 179
Time in range in pregnancy: is there a role?
Wyckoff, J. A., & Brown, F. M. (2021) · Diabetes Spectrum · doi:10.2337/ds20-0103 · Cited by 39
Li, L.-Q., Yao, M.-Y., Ma, J.-X., Xue, P., & Li, Y.-K. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej19-0016 · Cited by 20
Metadata
- Authors
- Scott, E. M., Bilous, R. W., & Kautzky-Willer, A.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2018-03
- Volume
- 20
- Issue
- 3
- Pages
- 180-188
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W2788883362
- Cited by
- 153
- References
- 16
- FWCI
- 10.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.